TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Orifarm Generics AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
736,638
|
586,893
|
461,376 |
| Financial expenses |
786
|
285
|
458 |
| Earnings before taxes |
15,482
|
11,478
|
12,065 |
| EBITDA |
14,733
|
10,271
|
8,074 |
| Total assets |
133,530
|
152,281
|
104,653 |
| Current assets |
126,183
|
145,487
|
99,256 |
| Current liabilities |
100,625
|
121,101
|
77,310 |
| Equity capital |
32,906
|
31,180
|
27,343 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
10
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
24.6%
|
20.5%
|
26.1% |
| Turnover per employee |
73,664
|
195,631
|
153,792 |
| Profit as a percentage of turnover |
2.1%
|
2.0%
|
2.6% |
| Return on assets (ROA) |
12.2%
|
7.7%
|
12.0% |
| Current ratio |
125.4%
|
120.1%
|
128.4% |
| Return on equity (ROE) |
47.0%
|
36.8%
|
44.1% |
| Change turnover |
139,163
|
92,779
|
-6,865 |
| Change turnover % |
23%
|
19%
|
-1% |
| Chg. No. of employees |
7
|
0
|
0 |
| Chg. No. of employees % |
233%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.